Saar I Gill

15PUBLICATIONS
105CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Micro-manipulationCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Mar 10, 2026
Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancer.

Gregory M Chen, Ankita Jain, David T Gering

|Mar 20, 2025
Author Correction: Chimeric antigen receptor macrophages (CAR-M) sensitize HER2+ solid tumors to PD1 blockade in pre-clinical models.

Stefano Pierini, Rashid Gabbasov, Maria Cecilia Oliveira-Nunes

|Jan 15, 2025
Chimeric antigen receptor macrophages (CAR-M) sensitize HER2+ solid tumors to PD1 blockade in pre-clinical models.

Stefano Pierini, Rashid Gabbasov, Maria Cecilia Oliveira-Nunes

|Sep 09, 2024
CD45 threads the needle of cytokine cancer immunotherapy.

Nils Wellhausen, Saar Gill

|Jun 13, 2024
Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors.

Ju-Fang Chang, Nils Wellhausen, Nils W Engel

|May 20, 2024
The Glucose Transporter 5 Enhances CAR-T Cell Metabolic Function and Anti-tumour Durability.

Bakir Valentić, Andre Kelly, Alexander A Shestov

Pageof 3

Frequent Collaborators

5 joint publications

Carl H June

4 joint publications

Joseph A Fraietta

4 joint publications

Marco Ruella

2 joint publications

Nils Wellhausen